Lesion distribution characteristics of deep infiltrating endometriosis with ovarian endometrioma: an observational clinical study.


Journal

BMC women's health
ISSN: 1472-6874
Titre abrégé: BMC Womens Health
Pays: England
ID NLM: 101088690

Informations de publication

Date de publication:
20 05 2020
Historique:
received: 19 12 2019
accepted: 10 05 2020
entrez: 22 5 2020
pubmed: 22 5 2020
medline: 13 11 2020
Statut: epublish

Résumé

To investigate the characteristics of deep infiltrating endometriosis (DIE) lesion distribution when associated with ovarian endometrioma (OEM). The present study analyzed retrospective data obtained by the First Affiliated Hospital of Sun Yat-sen University, between June 2008 to June 2016. A total of 304 patients underwent laparoscopic surgery for complete removal of endometriosis by one experienced surgeon, and histological confirmation of OEM associated with DIE was conducted for each patient. Clinical data were recorded for each patient from medical, operative and pathological reports. Patients were then divided into two groups according to unilateral or bilateral OEM. Patients with unilateral OEM were subsequently divided into two subgroups according to OEM location (left- or right-hand side) and the diameter of the OEM (≤50 and > 50 mm). The distribution characteristics of DIE lesions were then compared between the groups. DIE lesions were widely distributed, 30 anatomical sites were involved. Patients with associated unilateral OEM (n = 184 patients) had a significantly increased number of DIE lesions when compared with patients with bilateral OEM (n = 120 patients; 2.76 ± 1.52 vs. 2.33 ± 1.34; P = 0.006). Compared with bilateral OEM with DIE, there was a higher rate of intestinal (39.1% vs. 18.3%; P < 0.01) and vaginal (17.4% vs. 6.7%; P < 0.01) infiltration by DIE lesions in unilateral OEM with DIE. The mean number of DIE lesions was not significantly correlated with the location or size of the OEM (2.83 ± 1.56 vs. 2.74 ± 1.53; P = 0.678; and 2.65 ± 1.42 vs. 2.80 ± 1.43; P = 0.518, respectively). There was no significant difference between the groups with OEM ≤50 mm and > 50 mm. Lesion distribution characteristics in women diagnosed with histologically proven OEM associated with DIE were frequently multifocal and severe.

Sections du résumé

BACKGROUND
To investigate the characteristics of deep infiltrating endometriosis (DIE) lesion distribution when associated with ovarian endometrioma (OEM).
METHODS
The present study analyzed retrospective data obtained by the First Affiliated Hospital of Sun Yat-sen University, between June 2008 to June 2016. A total of 304 patients underwent laparoscopic surgery for complete removal of endometriosis by one experienced surgeon, and histological confirmation of OEM associated with DIE was conducted for each patient. Clinical data were recorded for each patient from medical, operative and pathological reports. Patients were then divided into two groups according to unilateral or bilateral OEM. Patients with unilateral OEM were subsequently divided into two subgroups according to OEM location (left- or right-hand side) and the diameter of the OEM (≤50 and > 50 mm). The distribution characteristics of DIE lesions were then compared between the groups.
RESULTS
DIE lesions were widely distributed, 30 anatomical sites were involved. Patients with associated unilateral OEM (n = 184 patients) had a significantly increased number of DIE lesions when compared with patients with bilateral OEM (n = 120 patients; 2.76 ± 1.52 vs. 2.33 ± 1.34; P = 0.006). Compared with bilateral OEM with DIE, there was a higher rate of intestinal (39.1% vs. 18.3%; P < 0.01) and vaginal (17.4% vs. 6.7%; P < 0.01) infiltration by DIE lesions in unilateral OEM with DIE. The mean number of DIE lesions was not significantly correlated with the location or size of the OEM (2.83 ± 1.56 vs. 2.74 ± 1.53; P = 0.678; and 2.65 ± 1.42 vs. 2.80 ± 1.43; P = 0.518, respectively). There was no significant difference between the groups with OEM ≤50 mm and > 50 mm.
CONCLUSION
Lesion distribution characteristics in women diagnosed with histologically proven OEM associated with DIE were frequently multifocal and severe.

Identifiants

pubmed: 32434535
doi: 10.1186/s12905-020-00974-y
pii: 10.1186/s12905-020-00974-y
pmc: PMC7240912
doi:

Types de publication

Journal Article Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

111

Subventions

Organisme : Natural Science Foundation of China
ID : 81070472
Pays : International
Organisme : Science and Technology Planning Project of Guangdong Province
ID : 2012B031800121
Pays : International

Références

J Obstet Gynaecol. 2018 Feb;38(2):257-260
pubmed: 28969477
Eur J Obstet Gynecol Reprod Biol. 2017 Feb;209:55-60
pubmed: 26688210
Hum Reprod. 2003 Sep;18(9):1922-7
pubmed: 12923150
Fertil Steril. 1996 Dec;66(6):920-4
pubmed: 8941055
Fertil Steril. 1999 Aug;72(2):310-5
pubmed: 10439002
Rev Bras Ginecol Obstet. 2012 Sep;34(9):420-4
pubmed: 23197281
Nat Rev Endocrinol. 2014 May;10(5):261-75
pubmed: 24366116
Am J Obstet Gynecol. 2005 Dec;193(6):1908-14
pubmed: 16325591
Fertil Steril. 2005 Apr;83(4):908-13
pubmed: 15820799
Fertil Steril. 1991 Apr;55(4):759-65
pubmed: 2010001
J Minim Invasive Gynecol. 2013 Jan-Feb;20(1):49-55
pubmed: 23131702
J Minim Invasive Gynecol. 2005 Sep-Oct;12(5):409-14
pubmed: 16213426
Acta Obstet Gynecol Scand. 2015 Jan;94(1):72-9
pubmed: 25256374
J Minim Invasive Gynecol. 2020 Jan;27(1):100-106
pubmed: 30849476
Urol J. 2015 Sep 04;12(4):2213-7
pubmed: 26341760
Updates Surg. 2014 Mar;66(1):59-64
pubmed: 24288011
Hum Reprod. 2004 Jan;19(1):168-71
pubmed: 14688177
Hum Reprod Update. 2009 Jul-Aug;15(4):441-61
pubmed: 19279046
Hum Reprod. 2012 Mar;27(3):702-11
pubmed: 22252082
Zhonghua Fu Chan Ke Za Zhi. 2013 Feb;48(2):118-22
pubmed: 23544493
Fertil Steril. 2009 Aug;92(2):453-7
pubmed: 18692806
Best Pract Res Clin Obstet Gynaecol. 2016 Aug;35:51-62
pubmed: 26694586
Hum Reprod. 2003 Jan;18(1):157-61
pubmed: 12525459
Zhonghua Fu Chan Ke Za Zhi. 2010 Feb;45(2):93-8
pubmed: 20420777
Fertil Steril. 2009 Dec;92(6):2074-7
pubmed: 19591996
Urol J. 2009 Spring;6(2):132-4
pubmed: 19472135
J Minim Invasive Gynecol. 2005 Nov-Dec;12(6):508-13
pubmed: 16337578
Minim Invasive Ther Allied Technol. 2005;14(3):160-6
pubmed: 16754158
Ginekol Pol. 2005 Jan;76(1):33-6
pubmed: 15844563
Acta Obstet Gynecol Scand. 2006;85(11):1375-80
pubmed: 17091420
Abdom Radiol (NY). 2016 Dec;41(12):2404-2410
pubmed: 27590068
Eur J Obstet Gynecol Reprod Biol. 2008 Jun;138(2):127-34
pubmed: 18336988
Hum Reprod. 2002 Feb;17(2):432-5
pubmed: 11821290
Urol Int. 2013;91(1):1-9
pubmed: 23689345
Fertil Steril. 1990 Jun;53(6):978-83
pubmed: 2140994
Int J Clin Exp Med. 2015 Nov 15;8(11):21497-506
pubmed: 26885098
Surg Endosc. 2010 Jan;24(1):63-7
pubmed: 19466489
J Gynecol Obstet Biol Reprod (Paris). 2014 Jan;43(1):12-8
pubmed: 23265672
Am J Obstet Gynecol. 2000 Mar;182(3):540-4
pubmed: 10739505

Auteurs

Hungling Kwok (H)

Department of Obstetrics and Gynecology, the Seventh Affiliated Hospital of Sun Yat-sen University, Shenzhen, China.

Hongye Jiang (H)

Department of Obstetrics and Gynecology, the First Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510000, China.

Tian Li (T)

Department of Obstetrics and Gynecology, the Seventh Affiliated Hospital of Sun Yat-sen University, Shenzhen, China.

Huan Yang (H)

Department of Gynecology, Shenzhen Second People's Hospital/ the First Affiliated Hospital of Shenzhen University Health Science Center, Shenzhen, China.

Hui Fei (H)

Department of Obstetrics and Gynecology, the Seventh Affiliated Hospital of Sun Yat-sen University, Shenzhen, China.

Li Cheng (L)

Department of Obstetrics and Gynecology, the Seventh Affiliated Hospital of Sun Yat-sen University, Shenzhen, China.

Shuzhong Yao (S)

Department of Obstetrics and Gynecology, the First Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510000, China.

Shuqin Chen (S)

Department of Obstetrics and Gynecology, the First Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510000, China. chenshuqin1021@163.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH